background image

AbbVie Clinical Trials

Find clinical trials for AbbVie. Search for AbbVie clinical trials in different cities and states across the United States.

Filter
Active & Responsive

A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume

for
Mid Face Volume Deficit
Location: Latham NY, Baltimore MD, Arlington VA, Coral Gables FL,
Sponsor: AbbVie

Sex: All

Age: 22+

Code: NCT06734351

Phase3, Recruiting
Active & Responsive

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

for
Migraine
Location: Miami FL, Los Angeles CA, Summerville SC, Tampa FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 70

Code: NCT06602479

Phase2, Recruiting
Active & Responsive

Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder

for
Bipolar I or II Disorder
Location: Cromwell CT, Springfield MA, Cedarhurst NY, Brooklyn NY,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07220460

Phase2, Recruiting
Active & Responsive

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

for
Major Depressive Disorder
Location: New York NY, Hollywood FL, Miami FL, Orlando FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07276997

Phase2, Recruiting
Active & Responsive

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

for
Rheumatoid Arthritis
Location: Sherbrooke, Great Neck NY, West Long Branch NJ,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06972446

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder (GAD)
Location: Cromwell CT, Springfield MA, Brooklyn NY, Toms River NJ,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06846320

Phase2, Recruiting
Active & Responsive

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

for
Migraine
Location: Boston MA, Waltham MA, Cumberland RI,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06417775

Phase3, Recruiting
Active & Responsive

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

for
Bipolar I Disorder, Bipolar II Disorder
Location: New York NY, Pompano Beach FL, West Palm Beach FL,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06696755

Phase2, Recruiting
Active & Responsive

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

for
Hypothyroidism
Location: Boston MA, Dracut MA, Nashua NH, Smithtown NY,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06345339

Phase2, Phase3, Recruiting
Active & Responsive

A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

for
Juvenile Psoriatic Arthritis
Location: Valhalla NY, New York NY, Washington D.C. DC,
Sponsor: AbbVie

Sex: All

Age: 5 - 17

Code: NCT06100744

Phase3, Recruiting